[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fpHPtemNAAFtp16jj5zcmUN0NEVmhaeh5E6QzXqAa94s":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":13,"question":19,"related":20,"source":31,"type":32},[],"2023-05-07 20:51:09",898261084,[8,9,10,11,12],"48小时","12 - 24小时","0 - 4小时","2-3天","4天(96小时)",{"courseId":14,"courseImg":15,"courseName":16,"workId":17,"workName":18},"1000011079","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F3f48d3e337224881af53a3f56da38070.png","医学免疫学","41729987","医学免疫学教程考试","单核细胞在血液中停留时间约为( )",[21,33,43,46,56,66,76,86,96,106],{"answer":22,"createTime":5,"id":23,"options":24,"question":30,"source":31,"type":32},[],898261079,[25,26,27,28,29],"染后0-4小时内","感染后4-96小时内","感染后24-48小时内","感染后96小时内","感染后4-5天","即刻非特异性免疫应答发生在感染后( )","v2",0,{"answer":34,"createTime":5,"id":35,"options":36,"question":42,"source":31,"type":32},[],898261080,[37,38,39,40,41],"病原菌感染机体96小时后发生","经克隆扩增和分化","作用时间长","需抗原提呈细胞处理抗原","无免疫记忆","关于非特异性免疫,正确的是( )",{"answer":44,"createTime":5,"id":6,"options":45,"question":19,"source":31,"type":32},[],[8,9,10,11,12],{"answer":47,"createTime":5,"id":48,"options":49,"question":55,"source":31,"type":32},[],898261088,[50,51,52,53,54],"抗原和免疫佐剂联合使用","单独使用抗原","抗原和免疫抑制剂联合使用","接种卡介苗","抗原和有丝分裂原联合使用","为诱导成年机体发生免疫耐受,常用的方法是( )",{"answer":57,"createTime":5,"id":58,"options":59,"question":65,"source":31,"type":32},[],898261089,[60,61,62,63,64],"免疫耐受是特异性的免疫无应答","T细胞比B细胞易于诱导对抗原的耐受性","诱导T细胞或B细胞产生耐受所需的抗原剂量不同","淋巴细胞在胚胎期接触过的抗原,出生后再次接触可以产生免疫耐受","机体对TI-Ag的耐受是T细胞介导的","下列对免疫耐受性的描述哪项是错误的( )",{"answer":67,"createTime":5,"id":68,"options":69,"question":75,"source":31,"type":32},[],898261091,[70,71,72,73,74],"T细胞形成耐受性出现较早,维持时间较短","B细胞形成耐受性出现较早,维持时间较短","T细胞形成耐受性出现较早,维持时间较长","B细胞形成耐受性出现较早,维持时间较长","T,B细胞形成耐受性所需时间和耐受性维持时间大致相同","T细胞和B细胞形成免疫耐受的规律是( )",{"answer":77,"createTime":5,"id":78,"options":79,"question":85,"source":31,"type":32},[],898261092,[80,81,82,83,84],"机体对抗原刺激表现为免疫不应答的现象","即Ag不能激活T与B细胞完成和执行正免疫应答","具有特异性","对任何Ag均不应答","免疫耐受的作用与正免疫应答相反","免疫耐受错误的描述是( )",{"answer":87,"createTime":5,"id":88,"options":89,"question":95,"source":31,"type":32},[],898261094,[90,91,92,93,94],"皮内注射聚合的抗原","静脉注射聚合的抗原","肌肉注射非聚合的抗原","静脉注射非聚合的抗原","皮内\u002F皮下同时注射抗原","诱导免疫耐受时宜采用下列哪种方法( )",{"answer":97,"createTime":5,"id":98,"options":99,"question":105,"source":31,"type":32},[],898261098,[100,101,102,103,104],"单核细胞巨噬细胞","中性粒细胞,肥大细胞","中性粒细胞,嗜碱性粒细胞","肥大细胞,嗜碱性粒细胞","嗜酸性粒细胞,嗜碱性粒细胞","下列哪些细胞表达高亲和力的FcεRⅠ( )",{"answer":107,"createTime":5,"id":108,"options":109,"question":115,"source":31,"type":32},[],898261099,[110,111,112,113,114],"备解素","白三烯","前列腺素","组胺","血小板活化因子","下列生物活性介质中哪一种与I型超敏反应的发生关系不大( )"]